Tumor and immune determinants of response to anti-BCMA CAR T-cell therapy in multiple myeloma using cell-free DNA

被引:0
|
作者
Carleton, Mia
Hosoya, Hitomi
Tanaka, Kailee L.
Sworder, Brian
Hovanky, Vanna
Sahaf, Bita
Frank, Matthew J.
Duran, George E.
Zhang, Tian Y.
Arai, Sally
Iberri, David
Liedtke, Michaela
Miklos, David B.
Khodadoust, Michael S.
Sidana, Surbhi
Kurtz, David M.
机构
关键词
D O I
10.1158/1538-7445.AM2023-5707
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5707
引用
收藏
页数:3
相关论文
共 50 条
  • [21] BCMA CAR T-cell therapy arrives for multiple myeloma: a reality
    Cho, Shih-Feng
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [22] BCMA-directed CAR T-cell therapy in multiple myeloma
    Cookson, Emma
    LANCET HAEMATOLOGY, 2020, 7 (07): : E505 - E505
  • [23] Ciltacabtagene autoleucel: The second anti-BCMA CAR T-cell therapeutic armamentarium of relapsed or refractory multiple myeloma
    Chekol Abebe, Endeshaw
    Yibeltal Shiferaw, Mestet
    Tadele Admasu, Fitalew
    Asmamaw Dejenie, Tadesse
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Updated Phase 1 Results of C-CAR088, an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma
    Qu, Xiaoyan
    An, Gang
    Sui, Weiwei
    Wang, Tingyu
    Zhang, Xian
    Yang, Junfang
    Zhang, Yan
    Zhang, Lu
    Zhu, Judy
    Huang, Jiaqi
    Li, Jing
    Zheng, Shirley
    Zhu, Kevin
    Lan, Liping
    Chen, Shiyi
    Humphries, Michael
    Yao, Yihong
    Zhou, Daobin
    Lu, Peihua
    Qiu, Lugui
    Li, Jianyong
    BLOOD, 2021, 138 : 1830 - +
  • [25] Outcomes of Anti-BCMA CAR T Cell Therapy for Relapsed/refractory Multiple Myeloma: A Meta-Analysis
    Gagelmann, Nico
    Ayuk, Francis
    Atanackovic, Djordje
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 130 - 130
  • [26] Exhaustion and Activation Status in Apheresed T Cells Correlate with Response to Anti-BCMA CAR T Cell Therapy in Myeloma
    Wang, Meng
    Pruteanu-Malinici, Iulian
    Cohen, Adam
    Garfall, Alfred
    Tian, Lifeng
    Lacey, Simon F.
    Fraietta, Joseph
    Brogdon, Jennifer
    Davis, Megan
    Gonzalez, Vanessa
    Levine, Bruce L.
    Siegel, Donald L.
    Milone, Michael C.
    Stadtmauer, Edward A.
    June, Carl H.
    Melenhorst, J. Joseph
    MOLECULAR THERAPY, 2020, 28 (04) : 573 - 574
  • [27] A phase I study of anti-BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia
    Li, Chunrui
    Cao, Wenyue
    Que, Yimei
    Wang, Qiuxiang
    Xiao, Yi
    Gu, Chaojiang
    Wang, Di
    Wang, Jue
    Jiang, Lijun
    Xu, Hao
    Xu, Jinhuan
    Zhou, Xiaoxi
    Hong, Zhenya
    Wang, Na
    Huang, Liang
    Zhang, Shangkun
    Chen, Liting
    Mao, Xia
    Xiao, Min
    Zhang, Wei
    Meng, Li
    Cao, Yang
    Zhang, Tongcun
    Li, Jian
    Zhou, Jianfeng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (03):
  • [28] Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Nakashima, J. Y.
    Khatri, V.
    Cruz-Chamorro, R. J.
    Zhou, J.
    Patra, P.
    Gonzalez, R.
    De Avila, G.
    Locke, F. L.
    Liu, H. D.
    Nishihori, T.
    Puglianini, O. C.
    Alsina, M.
    Garjales-Cruz, A.
    Baz, R.
    Shah, B. D.
    Shain, K.
    Jain, M. D.
    Hansen, D.
    Freeman, C.
    Figura, N. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S206 - S207
  • [29] An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma
    An, Gang
    Sui, Weiwei
    Wang, Tingyu
    Qu, Xiaoyan
    Zhang, Xian
    Yang, Junfang
    Zhang, Yan
    Zhang, Lu
    Zhu, Judy
    Zheng, Chengxiao
    Yan, Xiuxiu
    Lv, Xiaoteng
    Lan, Liping
    Yang, Dingzhu
    Huo, Ningning
    Han, Ting
    Zhao, Dijun
    Qin, Shichao
    Wu, Junfeng
    Yao, Xin
    Zhu, Shigui
    Ren, Jiaqiang
    Zhang, Li
    Huang, Jiaqi
    Humphries, Michael
    Yao, Yihong
    Zhou, Daobin
    Li, Jianyong
    Lu, Peihua
    BLOOD, 2020, 136
  • [30] Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma
    van de Donk, Niels W. C. J.
    Themeli, Maria
    Usmani, Saad Z.
    BLOOD CANCER DISCOVERY, 2021, 2 (04): : 302 - 318